NOV INC (NOV) Fundamental Analysis & Valuation

NYSE:NOV • US62955J1034

Current stock price

20.5 USD
+0.28 (+1.38%)
At close:
20.6 USD
+0.1 (+0.49%)
After Hours:

This NOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NOV Profitability Analysis

1.1 Basic Checks

  • NOV had positive earnings in the past year.
  • In the past year NOV had a positive cash flow from operations.
  • Of the past 5 years NOV 4 years were profitable.
  • Of the past 5 years NOV 4 years had a positive operating cash flow.
NOV Yearly Net Income VS EBIT VS OCF VS FCFNOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B

1.2 Ratios

  • The Return On Assets of NOV (1.28%) is comparable to the rest of the industry.
  • The Return On Equity of NOV (2.31%) is comparable to the rest of the industry.
  • The Return On Invested Capital of NOV (4.29%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NOV is below the industry average of 7.00%.
Industry RankSector Rank
ROA 1.28%
ROE 2.31%
ROIC 4.29%
ROA(3y)5.22%
ROA(5y)2.92%
ROE(3y)9.46%
ROE(5y)5.28%
ROIC(3y)4.81%
ROIC(5y)N/A
NOV Yearly ROA, ROE, ROICNOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • The Profit Margin of NOV (1.66%) is comparable to the rest of the industry.
  • NOV's Profit Margin has declined in the last couple of years.
  • The Operating Margin of NOV (7.47%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of NOV has grown nicely.
  • The Gross Margin of NOV (21.03%) is worse than 61.29% of its industry peers.
  • In the last couple of years the Gross Margin of NOV has grown nicely.
Industry RankSector Rank
OM 7.47%
PM (TTM) 1.66%
GM 21.03%
OM growth 3Y28.51%
OM growth 5YN/A
PM growth 3Y-8.17%
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y24.49%
NOV Yearly Profit, Operating, Gross MarginsNOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NOV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NOV is destroying value.
  • Compared to 1 year ago, NOV has less shares outstanding
  • Compared to 5 years ago, NOV has less shares outstanding
  • NOV has a better debt/assets ratio than last year.
NOV Yearly Shares OutstandingNOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
NOV Yearly Total Debt VS Total AssetsNOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 2.13 indicates that NOV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.13, NOV perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • NOV has a debt to FCF ratio of 2.26. This is a good value and a sign of high solvency as NOV would need 2.26 years to pay back of all of its debts.
  • NOV has a better Debt to FCF ratio (2.26) than 75.81% of its industry peers.
  • NOV has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • NOV's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. NOV outperforms 62.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 2.26
Altman-Z 2.13
ROIC/WACC0.57
WACC7.58%
NOV Yearly LT Debt VS Equity VS FCFNOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • NOV has a Current Ratio of 2.42. This indicates that NOV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of NOV (2.42) is better than 70.97% of its industry peers.
  • NOV has a Quick Ratio of 1.67. This is a normal value and indicates that NOV is financially healthy and should not expect problems in meeting its short term obligations.
  • NOV's Quick ratio of 1.67 is fine compared to the rest of the industry. NOV outperforms 62.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.67
NOV Yearly Current Assets VS Current LiabilitesNOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NOV Growth Analysis

3.1 Past

  • The earnings per share for NOV have decreased strongly by -64.60% in the last year.
  • Measured over the past years, NOV shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.70% on average per year.
  • Looking at the last year, NOV shows a decrease in Revenue. The Revenue has decreased by -1.42% in the last year.
  • Measured over the past years, NOV shows a small growth in Revenue. The Revenue has been growing by 7.50% on average per year.
EPS 1Y (TTM)-64.6%
EPS 3Y1.2%
EPS 5Y13.7%
EPS Q2Q%-104.88%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y6.51%
Revenue growth 5Y7.5%
Sales Q2Q%-1.34%

3.2 Future

  • NOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.10% yearly.
  • NOV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.27% yearly.
EPS Next Y77.8%
EPS Next 2Y48.76%
EPS Next 3Y40.68%
EPS Next 5Y21.1%
Revenue Next Year-0.05%
Revenue Next 2Y1.86%
Revenue Next 3Y2.41%
Revenue Next 5Y1.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NOV Yearly Revenue VS EstimatesNOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
NOV Yearly EPS VS EstimatesNOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. NOV Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 35.96 indicates a quite expensive valuation of NOV.
  • Compared to the rest of the industry, the Price/Earnings ratio of NOV is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.42. NOV is valued slightly more expensive when compared to this.
  • Based on the Price/Forward Earnings ratio of 20.23, the valuation of NOV can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 64.52% of the companies listed in the same industry.
  • NOV is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 35.96
Fwd PE 20.23
NOV Price Earnings VS Forward Price EarningsNOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NOV is valued a bit cheaper than 75.81% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NOV indicates a rather cheap valuation: NOV is cheaper than 93.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.44
EV/EBITDA 7.76
NOV Per share dataNOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NOV's earnings are expected to grow with 40.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)2.63
EPS Next 2Y48.76%
EPS Next 3Y40.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NOV Dividend Analysis

5.1 Amount

  • NOV has a Yearly Dividend Yield of 1.56%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.94, NOV pays a bit more dividend than its industry peers.
  • NOV's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.56%

5.2 History

  • On average, the dividend of NOV grows each year by 59.82%, which is quite nice.
  • NOV has paid a dividend for at least 10 years, which is a reliable track record.
  • As NOV did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)59.82%
Div Incr Years2
Div Non Decr Years5
NOV Yearly Dividends per shareNOV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • NOV pays out 131.03% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of NOV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP131.03%
EPS Next 2Y48.76%
EPS Next 3Y40.68%
NOV Yearly Income VS Free CF VS DividendNOV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B
NOV Dividend Payout.NOV Dividend Payout, showing the Payout Ratio.NOV Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NOV Fundamentals: All Metrics, Ratios and Statistics

NOV INC

NYSE:NOV (4/24/2026, 8:04:00 PM)

After market: 20.6 +0.1 (+0.49%)

20.5

+0.28 (+1.38%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners106.28%
Inst Owner Change-1.14%
Ins Owners0.47%
Ins Owner Change4.55%
Market Cap7.39B
Revenue(TTM)8.74B
Net Income(TTM)145.00M
Analysts71.67
Price Target20.68 (0.88%)
Short Float %7.17%
Short Ratio5.12
Dividend
Industry RankSector Rank
Dividend Yield 1.56%
Yearly Dividend0.51
Dividend Growth(5Y)59.82%
DP131.03%
Div Incr Years2
Div Non Decr Years5
Ex-Date03-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-82.27%
Min EPS beat(2)-107.93%
Max EPS beat(2)-56.61%
EPS beat(4)0
Avg EPS beat(4)-48.17%
Min EPS beat(4)-107.93%
Max EPS beat(4)-2.37%
EPS beat(8)3
Avg EPS beat(8)-14.95%
EPS beat(12)5
Avg EPS beat(12)-7.95%
EPS beat(16)8
Avg EPS beat(16)25.62%
Revenue beat(2)2
Avg Revenue beat(2)2.29%
Min Revenue beat(2)0.65%
Max Revenue beat(2)3.93%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-0.85%
Max Revenue beat(4)3.93%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)8
Avg Revenue beat(12)0.71%
Revenue beat(16)12
Avg Revenue beat(16)1.34%
PT rev (1m)2.47%
PT rev (3m)17.82%
EPS NQ rev (1m)-13.7%
EPS NQ rev (3m)-26.08%
EPS NY rev (1m)-2.19%
EPS NY rev (3m)-10.82%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 35.96
Fwd PE 20.23
P/S 0.85
P/FCF 8.44
P/OCF 5.91
P/B 1.18
P/tB 1.75
EV/EBITDA 7.76
EPS(TTM)0.57
EY2.78%
EPS(NY)1.01
Fwd EY4.94%
FCF(TTM)2.43
FCFY11.85%
OCF(TTM)3.47
OCFY16.92%
SpS24.25
BVpS17.38
TBVpS11.73
PEG (NY)0.46
PEG (5Y)2.63
Graham Number14.9301 (-27.17%)
Profitability
Industry RankSector Rank
ROA 1.28%
ROE 2.31%
ROCE 7.35%
ROIC 4.29%
ROICexc 5.2%
ROICexgc 7.19%
OM 7.47%
PM (TTM) 1.66%
GM 21.03%
FCFM 10.02%
ROA(3y)5.22%
ROA(5y)2.92%
ROE(3y)9.46%
ROE(5y)5.28%
ROIC(3y)4.81%
ROIC(5y)N/A
ROICexc(3y)5.57%
ROICexc(5y)N/A
ROICexgc(3y)7.61%
ROICexgc(5y)N/A
ROCE(3y)8.24%
ROCE(5y)N/A
ROICexgc growth 3Y30.92%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.35%
ROICexc growth 5YN/A
OM growth 3Y28.51%
OM growth 5YN/A
PM growth 3Y-8.17%
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y24.49%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 2.26
Debt/EBITDA 1.9
Cap/Depr 105.63%
Cap/Sales 4.29%
Interest Coverage 7.68
Cash Conversion 124.11%
Profit Quality 604.14%
Current Ratio 2.42
Quick Ratio 1.67
Altman-Z 2.13
F-Score5
WACC7.58%
ROIC/WACC0.57
Cap/Depr(3y)100.56%
Cap/Depr(5y)87.69%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.6%
EPS 3Y1.2%
EPS 5Y13.7%
EPS Q2Q%-104.88%
EPS Next Y77.8%
EPS Next 2Y48.76%
EPS Next 3Y40.68%
EPS Next 5Y21.1%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y6.51%
Revenue growth 5Y7.5%
Sales Q2Q%-1.34%
Revenue Next Year-0.05%
Revenue Next 2Y1.86%
Revenue Next 3Y2.41%
Revenue Next 5Y1.27%
EBIT growth 1Y-25.46%
EBIT growth 3Y36.88%
EBIT growth 5YN/A
EBIT Next Year60.92%
EBIT Next 3Y24.16%
EBIT Next 5Y13.14%
FCF growth 1Y-8.08%
FCF growth 3YN/A
FCF growth 5Y4.59%
OCF growth 1Y-4.06%
OCF growth 3YN/A
OCF growth 5Y6.2%

NOV INC / NOV Fundamental Analysis FAQ

What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 5 / 10 to NOV.


Can you provide the valuation status for NOV INC?

ChartMill assigns a valuation rating of 5 / 10 to NOV INC (NOV). This can be considered as Fairly Valued.


How profitable is NOV INC (NOV) stock?

NOV INC (NOV) has a profitability rating of 4 / 10.


What is the financial health of NOV INC (NOV) stock?

The financial health rating of NOV INC (NOV) is 7 / 10.


Can you provide the dividend sustainability for NOV stock?

The dividend rating of NOV INC (NOV) is 5 / 10 and the dividend payout ratio is 131.03%.